Medtronic Claims Share Gains In Cardiovascular And Neurostim
The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.
You may also be interested in...
The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021.
The company expects revenues across its businesses to rapidly return to their pre-pandemic growth rates in the second half of 2021.
The company has begun a limited release of the radial artery access devices it added to its neurovascular therapies business when it quietly acquired RIST Neurovascular in 2020.